Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Precision Therapy: When Is Better: Up Front or at Relapse?

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Precision Therapy: When Is Better: Up Front or at Relapse?
Moderator
Gideon Blumenthal
U.S. Food and Drug Administration, Silver Spring, MD, United States
from AACR Annual Meeting 2018 on April 16, 2018 5:00 PM-6:30 PM
Precision Therapy: When Is Better: Up Front or at Relapse?
Invited Speaker
Scott Kopetz
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2018 on April 16, 2018 5:00 PM-6:30 PM
Precision Therapy: When Is Better: Up Front or at Relapse?
  •  
  • Free
  • Unknown permission
    for presentation
  •  
  •  
Invited Speaker
Alice T Shaw
Massachusetts General Hosp. Cancer Ctr., Boston, MA, United States
from AACR Annual Meeting 2018 on April 16, 2018 5:00 PM-6:30 PM
Precision Therapy: When Is Better: Up Front or at Relapse?
Panel Discussion
Gideon Blumenthal
U.S. Food and Drug Administration, Silver Spring, MD, United States
Scott Kopetz
UT MD Anderson Cancer Ctr., Houston, TX, United States
Alice T Shaw
Massachusetts General Hosp. Cancer Ctr., Boston, MA, United States
from AACR Annual Meeting 2018 on April 16, 2018 5:00 PM-6:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4